HDACi - Targets beyond chromatin

被引：130

作者：

Buchwald, Marc ^{[1
]}

Kraemer, Oliver H. ^{[1
]}

Heinzel, Thorsten ^{[1
]}

机构：

[1] Univ Jena, CMB, Inst Biochem & Biophys, D-07745 Jena, Germany

来源：

CANCER LETTERS | 2009年 / 280卷 / 02期

关键词：

Acetylation; Proteasomal degradation; STATs; NF-kappaB; Signaling crosstalk; NF-KAPPA-B; HISTONE-DEACETYLASE INHIBITORS; NECROSIS-FACTOR-ALPHA; PROTEASOME INHIBITOR; PROTEIN-KINASE; VALPROIC ACID; CANCER-CELLS; IFN-GAMMA; TRANSCRIPTIONAL ACTIVATION; STIMULATED TRANSCRIPTION;

D O I：

10.1016/j.canlet.2009.02.028

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Histone deacetylases (HDACs) play an important role in gene regulation. Inhibitors of HDACs (HDACi) are novel anti-cancer drugs, which induce histone (hyper-) acetylation and Counteract aberrant gene repression. On the other hand, HDACi treatment can also result in decreased gene expression, and targeting HDACs affects more than chromatin. Recently, HDACi were shown to evoke non-histone protein acetylation, which can alter signaling networks relevant for tumorgenesis. Furthermore, HDACi can promote the degradation of (proto-) oncoproteins. Here, we summarize these findings and discuss how these substances could be beneficial for the treatment and prevention of human ailments, such as cancer and unbalanced immune functions. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

引用

页码：160 / 167

页数：8

共 87 条

[51] Lack of requirement of STAT1 for activation of nuclear factor-κB, c-Jun NH2-terminal protein kinase, and apoptosis by tumor necrosis factor-α [J].

Mukhopadhyay, A ;

Shishodia, S ;

Fu, XY ;

Aggarwal, BB .

JOURNAL OF CELLULAR BIOCHEMISTRY, 2002, 84 (04) :803-815

[52] Stat3 activation of NF-κB p100 processing involves CBP/p300-mediated acetylation [J].

Nadiminty, Nagalakshmi ;

Lou, Wei ;

Lee, Soo Ok ;

Lin, Xin ;

Trump, Donald L. ;

Gao, Allen C. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (19) :7264-7269

[53] Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1 [J].

Nusinzon, I ;

Horvath, CM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (25) :14742-14747

[54] Stat acetylation - A key facet of cytokine signaling? [J].

O'Shea, JJ ;

Kanno, Y ;

Chen, XM ;

Levy, DE .

SCIENCE, 2005, 307 (5707) :217-218

[55] Inhibitors of histone deacetylases induce tumor-selective cytotoxicity through modulating Aurora-A kinase [J].

Park, Jung-Hyun ;

Jong, Hyun-Soon ;

Kim, Sang Gyun ;

Jung, Yeonjoo ;

Lee, Keun-Wook ;

Lee, Ju-Hee ;

Kim, Dae-Kee ;

Bang, Yung-Jue ;

Kim, Tae-You .

JOURNAL OF MOLECULAR MEDICINE-JMM, 2008, 86 (01) :117-128

[56] IFN-Stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff [J].

Paulson, M ;

Press, C ;

Smith, E ;

Tanese, N ;

Levy, DE .

NATURE CELL BIOLOGY, 2002, 4 (02) :140-147

[57] Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors [J].

Pei, XY ;

Dai, Y ;

Grant, S .

CLINICAL CANCER RESEARCH, 2004, 10 (11) :3839-3852

[58] The 8; 21 translocation in leukemogenesis [J].

Peterson, LF ;

Zhang, DE .

ONCOGENE, 2004, 23 (24) :4255-4262

[59] NF-κB functions as a tumour promoter in inflammation-associated cancer [J].

Pikarsky, E ;

Porat, RM ;

Stein, I ;

Abramovitch, R ;

Amit, S ;

Kasem, S ;

Gutkovich-Pyest, E ;

Urieli-Shoval, S ;

Galun, E ;

Ben-Neriah, Y .

NATURE, 2004, 431 (7007) :461-466

[60] Mechanisms of type-I- and type-II-interferon-mediated signalling [J].

Platanias, LC .

NATURE REVIEWS IMMUNOLOGY, 2005, 5 (05) :375-386

← 1 2 3 4 5 6 7 8 9 →